ArticleBMC plant biology2026
Metabolomics reveals McF6'H1-mediated regulation of phenylpropanoid/flavonoid metabolism and enhanced antifungal activity in transgenic Morinda citrifolia.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Phenylpropanoids and flavonoids are major classes of bioactive metabolites that contribute to plant defense and functional value in noni (Morinda citrifolia). Although feruloyl-CoA 6'-hydroxylase 1 (F6'H1) is recognized as a key enzyme in coumarin biosynthesis, its broader role in secondary metabolic regulation and antifungal responses in perennial medicinal plants remains unclear. In this study, we investigated the regulatory function of McF6'H1 by transgenic analysis, HPLC-MS/MS-based metabolomics, and extract-based antifungal assays in noni. Based on an established genetic transformation system, stable McF6'H1 overexpression (OE) and RNA interference (RNAi) lines were obtained and subsequently subjected to HPLC-MS/MS based metabolomic profiling and antifungal evaluation against Phytophthora cactorum, powdery mildew, and Diaporthales. Metabolomic analysis showed that altered McF6'H1 expression was associated with pronounced changes in secondary metabolism, including phenylpropanoid, flavonoid, flavone, amino acid, and organic acid pathways. McF6'H1 overexpression was associated with increased accumulation of several phenylpropanoid and flavonoid related metabolites, including rutin, luteoloside, and other flavonol derivatives, and with stronger antifungal activity against a powdery mildew-associated fungal isolate and a Diaporthales fungal isolate. Interestingly, both OE and RNAi lines showed increased inhibition of P. cactorum, possibly because altered McF6'H1 expression triggered metabolic compensation or flux redistribution within the phenylpropanoid/coumarin network, leading to non-linear changes in antimicrobial metabolites. Overall, our results indicated that McF6'H1 was involved in phenylpropanoid/flavonoid metabolic reprogramming and antifungal responses in noni, providing a basis for further studies on metabolic regulation and disease resistance in medicinal plants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.